Lakefront Biotherapeutics | GLPG - Ebit





Ebit تغيير تاريخ
argenx SE USD 486M 7M 2026-09
AstraZeneca USD 4.66B 1.5B 2026-09
Biogen USD 419.5M 663.3M 2026-09
Genmab DKK 407M 221M 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
GRIFOLS EUR 394M 34M 2026-09
Hikma Pharmaceutical USD 348M 31M 2025-12
Incyte USD -707.47M 1.41B 2026-09
Merck EUR 660M 437M 2026-09
Neurocrine Biosciences USD 343M 123.1M 2026-09
Novartis USD 5.14B 411M 2026-09
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 4.72B 3.6B 2026-09
UCB EUR 1.29B 571M 2025-12
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09